Company Exploring Alternative Value Creation Opportunities
Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding.
04.06.2024 - Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ( Lobe or the Company ), a biopharmaceutical company focused on developing transformative medicines to treat diseases with unmet medical needs and rare diseases announced the evaluation of strategic . Seite 1